Prolonged cytotoxic effect of aqueous extracts from dried Viscum album on bladder cancer cells

Pharmazie

Volumn 62, Issue 3, 2007, Pages 237-238

  Hunziker Basler, N ^a   Zuzak, T J ^a   Eggenschwiler, J ^a   Rist, L ^b   Simões Wüst, A Paula ^b   Viviani, A ^a  

^a ZURICH UNIVERSITY OF APPLIED SCIENCES   (Switzerland)

^b Paracelsus Hospital   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VISCUM ALBUM EXTRACT;

AQUEOUS SOLUTION; ARTICLE; BLADDER CANCER; CANCER; CANCER CELL CULTURE; CLINICAL RESEARCH; COLORIMETRY; CYTOTOXICITY; HUMAN; NONHUMAN; VISCUM ALBUM;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; PLANT EXTRACTS; TETRAZOLIUM SALTS; THIAZOLES; URINARY BLADDER NEOPLASMS; VISCUM;

EID: 33947390838     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.3.6765     Document Type: Article

References (11)

1. American Cancer Society (2005) Cancer Facts and Figures 2005. Atlanta.
2. Eggenschwiler J, Patrignani A, Wagner U, Rehrauer H, Schlapbach R, Rist L, Ramos MH & Viviani A (2006) Gene expression profiles of different breast cancer cells compared with their responsiveness to fermented mistletoe (Viscum album L.) extracts Iscador from oak (Quercus), pine (Pinus), white fir (Abies) and apple tree (Malus) in vitro. Arzneim.-Forsch 56: 483-496.
3. Elsässer-Beile U, Leiber C, Wetterauer U, Buhler P, Wolf P, Lucht M & Mengs U (2005) Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer. Anticancer Res 25: 4733-4736.
4. Huber R, Rostock M, Goedl R, Ludtke R, Urech K, Buck S, Klein R (2005) Mistletoe treatment induces GM-CSF- and IL-5 production by PBMC and increases blood granulocyte- and eosinophil counts: a placebo controlled randomized study in healthy subjects. Eur J Med Res 10: 411-418.
5. Knopfl-Sidler F, Viviani A, Rist L, Hensel A (2005) Human cancer cells exhibit in vitro individual receptiveness towards different mistletoe extracts. Pharmazie 60: 448-454.
6. Molassiotis A, Scott JA, Kearney N, Pud D, Magri M, Selvekerova S, Bruyns I, Fernadez-Ortega P, Panteli V, Margulies A, Gudmundsdottir G, Milovics L, Ozden G, Platin N, Patiraki E (2006) Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer 14: 260-267.
7. Pryme IF, Bardocz S, Pusztai A, Ewen SW (2006) Suppression of growth of tumour cell lines in vitro and tumours in vivo by mistletoe lectins. Histol Histopathol 21: 285-299.
8. Roach M, Small E, Reese DM, Carroll P (2001) Urologic and male genital cancers. In: Rubin P (ed.) Clinical oncology, a multidisciplinary approach for physicians and students New York.
9. Stein G, Henn W, von Laue H, Berg P (1998) Modulation of the cellular and humoral immune responses of tumor patients by mistletoe therapy. Eur J Med Res 3: 194-202.
10. Urech K, Buessing A, Thalmann G, Schaefermeyer H, Heusser P (2006) Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines. Anticancer Res 26: 3049-3055.
11. Zuzak TJ, Rist L, Eggenschwiler J, Grotzer MA, Viviani A (2006) Paediatric medulloblastoma cells are susceptible to Viscum album (mistletoe) preparations. Anticancer Res 26: 3485-3492.